Detalhe da pesquisa
1.
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.
Br J Clin Pharmacol
; 88(5): 2140-2155, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34773923
2.
Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660).
Br J Clin Pharmacol
; 83(12): 2813-2820, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28800383
3.
Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects.
Br J Clin Pharmacol
; 77(5): 808-20, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24152086
4.
The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects.
Br J Clin Pharmacol
; 75(6): 1478-87, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23116485
5.
The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing.
Respir Med
; 107(12): 1873-80, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24200619